12pm eastern time

Stocks2Watch's Virtual Investor Luncheon Agenda Updated for Tuesday November 30

Stocks2Watch Investor Series today announced their agenda is updated for the Virtual Investor Luncheon on Tuesday November 30. Individual investors, finance professionals, and analysts are invited to register now to attend the Luncheon.

REGISTER NOW AT: https://app.livestorm.co/stocks2watch/investor-luncheon-nov-30

About the Virtual Luncheon:

The luncheon is scheduled to start at 12pm Eastern, Tuesday, November 30 with special guest Bruce Campbell opening the lunch; gain market insight and find investment opportunities all safely in the comfort of your office/home using our latest technology.

AGENDA: (Eastern Time)

12:00PM: Market Commentary - Bruce Campbell, Portfolio Manager at StoneCastle Funds

12:15PM: Quipt Home Medical - TSXV: QIPT

12:30PM: PlantFuel Life - CSE: FUEL

12:45PM: Levitee Labs - CSE: LVT

1:00PM: New "Stocks2Watch" Picks by Bruce Campbell, Portfolio Manager at StoneCastle Funds

REGISTER NOW AT: https://app.livestorm.co/stocks2watch/investor-luncheon-nov-30

ABOUT STOCKS2WATCH:

Stocks2Watch hosts online and in-person interactive events for publicly traded companies to meet and present directly with investors. To learn more about Stocks2Watch and view a complete list of events, please visit www.stocks2watch.ca

CONTACT:

Neil Lock,
info@stocks2watch.ca
604-410-4888

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105171

News Provided by Newsfile via QuoteMedia

cse:lvtpsychedelics investing
The Conversation (0)
Levitee Labs

Levitee Labs

Transforming the Traditional Landscape of Mental Health, Addiction Treatment and Pain Management Treatment Across Multiple Verticals

Transforming the Traditional Landscape of Mental Health, Addiction Treatment and Pain Management Treatment Across Multiple Verticals Keep Reading...
Dried mushrooms in the center are surrounded by translucent capsules on a white background.

Executive Order Sparks New Phase for Psychedelic Biotech, Risks Remain

On April 18, President Trump was joined by top health officials in the Oval Office to sign Accelerating Medical Treatments For Serious Mental Illness, an executive order to expand research into ibogaine. This signals the strongest federal endorsement yet of psychedelic medicine as an alternative... Keep Reading...
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Company's clinical research operations and therapist training programs directly positioned to support accelerated research and commercialization timelinesNuminus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal... Keep Reading...
Emyria Limited

Emyria Launches Global Services Platform Targeting International Drug Sponsors

Emyria’s established, world-first, unique national clinical delivery network to drive a new services-led revenue stream focused on global drug sponsors.

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”), a leader in innovative mental health treatments, is pleased to announce the launch of its Empax Global Partnership Program, a new services platform enabling international drug sponsors to access Emyria’s established clinical delivery... Keep Reading...
Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with an emphasis on safe, evidence-based psychedelic-assisted therapies, is providing an update regarding its listing status on the... Keep Reading...
Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Corporate UpdateOver the past year,... Keep Reading...
Numinus Wellness Advises of a Change of Auditor

Numinus Wellness Advises of a Change of Auditor

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is advising of a change of its auditor. The Company's previous... Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

QIMC Announces Closing of $17.3 Million Bought Deal Offering, Including Full Exercise of Underwriter's Over-Allotment Option

New Found Gold Closes Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option for Gross Proceeds of $115M

Couloir Capital Is Pleased to Announce That It Has Initiated Research Coverage on Pinnacle Silver and Gold

Silverco Mining Executes Definitive Agreement for the Acquisition of Nuevo Silver

Related News

uranium investing

Global Uranium Producers Fast-Track Production to Meet Market Deficit

oil and gas investing

QIMC Announces Closing of $17.3 Million Bought Deal Offering, Including Full Exercise of Underwriter's Over-Allotment Option

precious metals investing

New Found Gold Closes Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option for Gross Proceeds of $115M

precious metals investing

Couloir Capital Is Pleased to Announce That It Has Initiated Research Coverage on Pinnacle Silver and Gold

precious metals investing

Silverco Mining Executes Definitive Agreement for the Acquisition of Nuevo Silver

base metals investing

Corcel Exploration Reports Positive Results from an Induced Polarization Survey at Yuma King, Arizona

precious metals investing

One Bullion Reports High Concentration of Gold During Artisanal Sampling Program at Vumba Project Which Yielded a 679 g/t Gold Sample